These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 28806317

  • 1. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
    Lu S, Wang S, Gao Q, Zhou M, Li Y, Cao P, Hong X, Shi H.
    J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
    [Abstract] [Full Text] [Related]

  • 2. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
    Lu S, Gao Q, Yu J, Li Y, Cao P, Shi H, Hong X.
    Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
    [Abstract] [Full Text] [Related]

  • 3. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
    Choi YS, Lee HJ, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Lee SK.
    Eur Radiol; 2017 Apr; 27(4):1344-1351. PubMed ID: 27436023
    [Abstract] [Full Text] [Related]

  • 4. 18F-FDG PET/CT in immunocompetent patients with primary central nervous system lymphoma: Differentiation from glioblastoma and correlation with DWI.
    Zhou W, Wen J, Hua F, Xu W, Lu X, Yin B, Geng D, Guan Y.
    Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
    [Abstract] [Full Text] [Related]

  • 5. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
    Xi YB, Kang XW, Wang N, Liu TT, Zhu YQ, Cheng G, Wang K, Li C, Guo F, Yin H.
    Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.
    Bao S, Watanabe Y, Takahashi H, Tanaka H, Arisawa A, Matsuo C, Wu R, Fujimoto Y, Tomiyama N.
    Magn Reson Med Sci; 2019 Jan 10; 18(1):53-61. PubMed ID: 29848919
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY, Bjørnerud A, Park JE, Lee BE, Kim JH, Kim HS.
    Eur Radiol; 2019 Oct 10; 29(10):5539-5548. PubMed ID: 30877463
    [Abstract] [Full Text] [Related]

  • 12. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    You SH, Yun TJ, Choi HJ, Yoo RE, Kang KM, Choi SH, Kim JH, Sohn CH.
    Eur Radiol; 2018 Sep 10; 28(9):3801-3810. PubMed ID: 29619520
    [Abstract] [Full Text] [Related]

  • 13. Primary brain lymphoma and glioblastoma: evaluation of DCE T1 and DSC T2 MRI perfusion findings.
    Soydan H, Sözmen Cılız D, Cesur T, Tezgör Aksakal E.
    Acta Radiol; 2024 Jul 10; 65(7):800-807. PubMed ID: 38798137
    [Abstract] [Full Text] [Related]

  • 14. [Value of Minimum Apparent Diffusion Coefficient in Peritumoral Edema in the Differential Diagnosis between Primary Central Nervous System Lymphoma and Glioblastoma].
    Li MG, Chen ZY, Liu G, Xiao HF, Chen XJ, Lou X, Ma L.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Apr 28; 40(2):146-150. PubMed ID: 29724302
    [Abstract] [Full Text] [Related]

  • 15. Radiomics features to distinguish glioblastoma from primary central nervous system lymphoma on multi-parametric MRI.
    Kim Y, Cho HH, Kim ST, Park H, Nam D, Kong DS.
    Neuroradiology; 2018 Dec 28; 60(12):1297-1305. PubMed ID: 30232517
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI.
    Song C, Cheng P, Cheng J, Zhang Y, Sun M, Xie S, Zhang X.
    Eur Radiol; 2020 Jan 28; 30(1):110-118. PubMed ID: 31372786
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
    Choi HS, Kim AH, Ahn SS, Shin NY, Kim J, Lee SK.
    Korean J Radiol; 2013 Jan 28; 14(3):487-92. PubMed ID: 23690718
    [Abstract] [Full Text] [Related]

  • 20. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E, Yoon YC, Kim JH, Kim K.
    Clin Radiol; 2017 Jul 28; 72(7):552-559. PubMed ID: 28325514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.